A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?
Diabetes/Metabolism Research and Reviews · 2024
DOI: 10.1002/dmrr.3715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, 2024. Verfasst von Basem M Mishriky und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Atrial Fibrillation, Diabetes Mellitus, Type 2, Symporters. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
BMM has served on Advisory Board Panels for AstraZeneca and Bayer. DMC and JRP report no conflicts of interest. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/dmrr.3715. The data that support the findings of this study are available from the corresponding author upon reasonable request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology, University of South Carolina/Prisma Health, Columbia, South Carolina, USA.
- Department of General Internal Medicine, Duke University Health System, Raleigh, USA.
- Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
- Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
ORCID-Profile: Basem M Mishriky
Zitieren
APA
Mishriky, B. M., Cummings, D. M., & Powell, J. R. (2024). A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3715
Vancouver
Mishriky BM, Cummings DM, Powell JR. A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3715
BibTeX
@article{Mishriky2024,
author = {Mishriky, Basem M and Cummings, Doyle M and Powell, James R},
title = {A meta‐analysis of randomized controlled trials evaluating sodium‐glucose co‐transporter 2 inhibitors and incidental atrial fibrillation—Is there a true benefit?},
journal = {Diabetes/Metabolism Research and Reviews},
year = {2024},
doi = {10.1002/dmrr.3715}
}
EUVIMED